Point-of-care lung ultrasound – also known as lung POCUS – is a safer, more reliable alternative to X-ray in diagnosing pneumonia that provides information quickly. Yet it’s not widely considered the standard of care.
Judges picked Sonavi Labs as the winner of the home health track at MedCity INVEST Digital Health. The Baltimore-based startup makes a smart stethoscope that can be used at home, and plans to seek FDA clearance for a feature to detect pneumonia.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The mortality rates at rural hospitals for certain conditions, including heart attacks and stroke, decreased in the years following a merger or an acquisition compared with facilities that remained independent, a new study shows. This is a departure from research done on the effects of M&A on urban hospitals.
Actemra reduced the percentage of patients with Covid-19 pneumonia who progressed to requiring mechanical ventilation, but did not show an improvement in mortality, time to discharge or improvement on an ordinal scale of clinical status. Results of the Phase III COVACTA study, announced in July, were negative.
St. Augustine, Florida-based Flagler Hospital used Ayasdi's artificial intelligence technology to take on its clinical variation problem, specifically within the realms of pneumonia and sepsis.
Art Medical, a company based in Israel and Palo Alto, has products that seek to prevent complications that can arise from intubation, including aspiration pneumonia, ventilator-associated pneumonia and acute kidney injury.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Bay Area startup SutroVax just raised $22 million for work in developing conjugate vaccines - and likely improving upon existing inoculations for pneumococcal conditions.